|
COYA Coya Therapeutics Inc 1835022 |
| Balance Sheet |
|
Current Assets
|
$53,262,679.00 |
|
Assets
|
$53,271,099.00 |
|
Current Liabilities
|
$3,546,541.00 |
|
Liabilities
|
$4,300,739.00 |
|
Equity
|
$48,970,360.00 |
|
Shares Out
|
23457183.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,208,530.00 |
|
Investing Cash Flow
|
$-885,000.00 |
| Market Analysis |
Market Cap
|
$95,705,306.64 |
|
Price
|
$4.16 |
|
BVPS
|
2.09 |
|
PB
|
1.95 |
|
EPS
|
-0.32 |
|
PS
|
136.83 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:35 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-1.27 |
|
|
2026-05-12 |
-0.32 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.13 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view COYA documents filed with the SEC.
COYA Filings
Clear
